Wednesday, June 10, 2026

pharma

Berlin-Chemie AG

Berlin-Chemie AG patent portfolio — 25 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

EU HQ
1890 Founded
EMA registrant Type
Company details
Status
Public
HQ
EU
Founded
1890
Programs
0
Drugs
0
Patents
25
Intelligence · Patents

Berlin-Chemie AG patents

25 pharmaceutical patents indexed for Berlin-Chemie AG. 2 expire within 24 months.

Berlin-Chemie AG has 25 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 2 expire within 24 months — use filters for patent-cliff planning.

Patent portfolio

  1. WO 2024252263

    COMPOSITIONS SOLIDES DE DICHLORHYDRATE D'ÉLACESTRANT, LEURS PROCÉDÉS DE FABRICATION ET MÉTHODES DE TRAITEMENT LES UTILISANT

    Expires Wed Dec 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. CA 3259243

    POLYTHÉRAPIE ANTICANCÉREUSE COMPRENANT UN INHIBITEUR DE BCL-2

    Expires Wed Jan 27 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. WO 2024023766

    POLYTHÉRAPIE À BASE D'INHIBITEUR DE P13K

    Expires Wed Jan 27 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. CA 3259252

    POLYTHÉRAPIE ANTICANCÉREUSE COMPRENANT UN INHIBITEUR DE FLT3

    Expires Wed Jan 27 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. WO 2022029639

    FORMULATIONS PHARMACEUTIQUES AMÉLIORÉES COMPRENANT DES INHIBITEURS DE PI3K

    Expires Wed Feb 05 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. US 2021015826

    ANTICANCER PHARMACEUTICAL COMPOSITIONS FOR COMBINED THERAPY

    Expires Wed Jan 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. US 2020040086

    PHARMACEUTICAL COMBINATIONS COMPRISING AN ANTI-LY75 ANTIBODY

    Expires Wed Feb 01 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. CA 3102476

    ASSOCIATIONS PHARMACEUTIQUES

    Expires Wed Dec 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  9. EP 3576795

    ORALES SCHILDDRÜSENTHERAPEUTIKUM

    Expires Tue Dec 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  10. WO 2019197609

    ANTICORPS DIRIGÉS CONTRE BST1 POUR PRÉVENIR OU TRAITER LE SYNDROME MYÉLODYSPLASIQUE

    Expires Wed Oct 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  11. DE 102017122807

    Orales Schilddrüsentherapeutikum

    Expires Wed Mar 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  12. CA 3070264

    ASSOCIATIONS PHARMACEUTIQUES COMPRENANT UN ANTICORPS ANTI-BST-1 ET UN ANALOGUE DE CYTIDINE

    Expires Wed Jan 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  13. EP 3169322

    DIÄTETISCHE ZUSAMMENSETZUNG MIT ANTIDYSLIPIDÄMISCHER AKTIVITÄT

    Expires Tue May 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  14. PH 12016500580

    CONJUGATED ANTIBODIES AGAINST LY75 FOR THE TREATMENT OF CANCER

    Expires Sun May 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  15. EP 2882753

    VERFAHREN ZUR HERSTELLUNG VON PEMETREXED UND EINEM LYSINSALZ DAVON

    Expires Tue Jun 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  16. PH 12013502690

    ANTIBODIES TO ADP-RIBOSYL CYCLASE 2

    Expires Sun Feb 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  17. WO 2007104583

    COMPRIMÉ SÉCABLE AVEC PRÉCISION

    Expires Wed Sep 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  18. DE 102005046769

    Lichtstabile, brivudinhaltige pharmazeutische Formulierung zur Behandlung von Augenherpes (Herpes Ophthalmicus)

    Expires Wed Mar 31 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  19. EP 1613300

    PHOTOSTABILISIERTE TOPISCHE FORMULIERUNGEN VON KETOPROFEN MIT ZWEI UV-FILTERN

    Expires Tue Jan 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  20. EP 1488787

    Topisch anzuwendende stabilisierte Arzneimittel enthaltend Ketoprofen

    Expires Tue Dec 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  21. CA 2470629

    PREPARATIONS TOPIQUES STABILISEES DE BRIVUDINE

    Expires Wed Jun 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  22. EP 1297826

    Pharmazeutische Zusammensetzung zur nasalen Verabreichung enthaltend einen NK-2 Antagonisten

    Expires Tue Mar 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  23. WO 03007994

    SCHILDDRÜSENTHERAPEUTIKA

    Expires Wed Jan 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  24. CA 2439319

    PROCEDE DE PREPARATION DE (E)-5-(2-BROMOVINYL)-2'-DESOXYURIDINE

    Expires Thu Sep 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  25. CA 2434743

    PREPARATIONS TOPIQUES DE BRIVUDINE STABILISEES

    Expires Wed Jul 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does Berlin-Chemie AG have?

25 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Berlin-Chemie AG patents expire?

2 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.